Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verteporfin PDT + Bevacizumab Timing in AMD
NCT00426998Phase 2Completed
- Sponsor
- Retinal Consultants Medical Group
- Start
- Apr 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in neovascular age-related macular degeneration (NVAMD), sponsored by Retinal Consultants Medical Group. Started Apr 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT00426998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426998.